Author Details
Bakulev, A. L., Saratov State Medical University named after V. I. Razumovsky, Ministry of Health of the Russian Federation, Russian Federation
Issue | Section | Title | File |
Vol 95, No 2 (2019) | ORIGINAL STUDIES | Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis |
![]() (Rus) |
Vol 95, No 4 (2019) | CLINICAL PRACTICE GUIDELINES | Dermatoscopy in the diagnosis of pigmented nevi |
![]() (Rus) |
Vol 95, No 4 (2019) | DRUG TREATMENT IN DERMATOVENEROLOGY | Results of the long-term observational noninterventional prospective study BODYGUARD in psoriasis patients |
![]() (Rus) |
Vol 95, No 5 (2019) | DRUG TREATMENT IN DERMATOVENEROLOGY | Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis |
![]() (Rus) |
![](https://kazanmedjournal.ru/files/journals/10/misc/interface/16.gif)
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 60448 от 30.12.2014.